Clarivate Stock News

Expanded global offerings allow life science companies to make confident, data-driven decisions tailored to their patient populations LONDON , Dec. 22, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired Patient Connect, a provider of patient engagement solutions that enable the measurement of clinical and commercial outcomes and inform the advancement of healthcare. Patient Connect patient engagement solutions improve patient outcomes by delivering clinical messaging to physicians and pharmacists at the point of patient contact. Clinical messaging is delivered in physician and pharmacist workflows, to help guide patients to better understand their treatment and disease and empower them to make informed healthcare decisions. Patient Connect has a global reach of 834,000 physicians, 600,000 pharmacists and 1,000,000,000 patients, by point of contact. From drug discovery, clinical development and portfolio strategy through commercial planning, market access and customer engagement, Clarivate offers a wide variety of solutions providing end-to-end research intelligence to life science organizations.

Providing key insights for building a successful artificial intelligence (AI) ecosystem LONDON, Dec. 20, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted inform

Providing key insights for building a successful artificial intelligence (AI) ecosystem LONDON, Dec. 20, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation and the KAIST Innovation Strategy and

Advances in Alzheimer''s, innovation in DNA vaccines, increased regulatory collaboration and the evolving impact of Artificial Intelligence, join Covid-19 as key stories and trends of 2021 LONDON, Dec. 16, 2021 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global

Park Avenue Securities LLC bought a new position in shares of Clarivate Plc (NYSE:CLVT) in the third quarter, Holdings Channel reports. The institutional investor bought 18,286 shares of the companys stock, valued at approximately $400,000. Several other institutional investors have also recently made changes to their positions in CLVT. Citigroup Inc. acquired a new stake []

Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) with the stream of -1.18% also noticed, India Clarivate Plc (NYSE:CLVT) encountered a rapid change of -2.61% in the last hour of The post Stock on the Run: Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT), Clarivate Plc (NYSE:CLVT) appeared first on Stocks Equity .

Simon Quick Advisors LLC acquired a new position in shares of Clarivate Plc (NYSE:CLVT) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 14,325 shares of the companys stock, valued at approximately $313,000. Several other institutional investors also recently bought []

Selecting 93 research and 93 development specialties in nine fields LONDON, Dec. 14, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, the Chinese Academy of Engineering (CAE), and the…

The shares of Clarivate Plc (NYSE: CLVT) have received a $30 price target from Goldman Sachs. These are the details.

Analysts expect Clarivate Plc (NYSE:CLVT) to post $500.65 million in sales for the current quarter, Zacks reports. Two analysts have issued estimates for Clarivates earnings. The highest sales estimate is $501.70 million and the lowest is $499.60 million. Clarivate reported sales of $455.60 million in the same quarter last year, which would suggest a positive []

Selecting 110 hot and 61 emerging research specialties in 11 areas of sciences and social sciences LONDON, Dec. 8, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing tru

New report investigates how telehealth can reduce healthcare disparities in the treatment of Black Americans LONDON, Dec. 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in pro

Clarivate Plc (NYSE:CLVT) at last check was buoying at $24.25 on Thursday, December 02 with a rise of 8.31% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $22.39 with its price kept floating in the range of $22.36 and $23.60 on Clarivate Plc (CLVT) At $24.25: Is It Worth Your Interest? Read More »

The stock price of Clarivate (NYSE: CLVT) increased by over 11% during intraday trading today. This is why it happened.

Deltec Asset Management LLC purchased a new position in Clarivate Plc (NYSE:CLVT) in the third quarter, HoldingsChannel.com reports. The firm purchased 98,500 shares of the companys stock, valued at approximately $2,157,000. A number of other institutional investors and hedge funds also recently modified their holdings of the business. Berman Capital Advisors LLC increased its position []